serw-MX  [xml]  
 


    
 DeCS Categories

C10 Nervous System Diseases .
C10.500 Nervous System Malformations .
C10.500.507 Malformations of Cortical Development .
C10.500.507.450 Malformations of Cortical Development, Group II .
C10.500.507.450.499 Lissencephaly .
C10.500.507.450.499.249 Cobblestone Lissencephaly .
C10.500.507.450.499.249.500 Walker-Warburg Syndrome .
C11 Eye Diseases .
C11.270 Eye Diseases, Hereditary .
C11.270.881 Walker-Warburg Syndrome .
C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities .
C16.131 Congenital Abnormalities .
C16.131.666 Nervous System Malformations .
C16.131.666.507 Malformations of Cortical Development .
C16.131.666.507.450 Malformations of Cortical Development, Group II .
C16.131.666.507.450.499 Lissencephaly .
C16.131.666.507.450.499.249 Cobblestone Lissencephaly .
C16.131.666.507.450.499.249.500 Walker-Warburg Syndrome .
C16.320 Genetic Diseases, Inborn .
C16.320.577 Muscular Dystrophies .
C16.320.577.750 Walker-Warburg Syndrome .
D02 Organic Chemicals .
D02.065 Amides .
D02.065.884 Sulfonamides .
D02.065.884.725 Sulfanilamides .
D02.065.884.725.853 Sulfamerazine .
D02.092 Amines .
D02.092.146 Aniline Compounds .
D02.092.146.807 Sulfanilamides .
D02.092.146.807.853 Sulfamerazine .
D02.241 Carboxylic Acids .
D02.241.081 Acids, Acyclic .
D02.241.081.251 Carbamates .
D02.241.081.251.415 Mebendazole .
D02.886 Sulfur Compounds .
D02.886.590 Sulfones .
D02.886.590.700 Sulfonamides .
D02.886.590.700.725 Sulfanilamides .
D02.886.590.700.725.853 Sulfamerazine .
D03 Heterocyclic Compounds .
D03.383 Heterocyclic Compounds, 1-Ring .
D03.383.742 Pyrimidines .
D03.383.742.698 Pyrimidinones .
D03.383.742.698.253 Barbiturates .
D03.383.742.698.253.434 Mephobarbital .
D03.383.742.698.253.593 Pentobarbital .
D03.383.742.698.253.762 Secobarbital .
D03.633 Heterocyclic Compounds, Fused-Ring .
D03.633.100 Heterocyclic Compounds, 2-Ring .
D03.633.100.103 Benzimidazoles .
D03.633.100.103.600 Mebendazole .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Secobarbital .
Sebar .
Secobarbital Sodium .
Seconal .
Seconal Sodium .
Sodium, Secobarbital .
Meballymal .
Quinalbarbitone .
A barbiturate that is used as a sedative. Secobarbital is reported to have no anti-anxiety activity. .
1.00
0585
 
Sulfamerazine .
Mebacid .
Trimetox .
Methylsulfadiazine .
A sulfanilamide that is used as an antibacterial agent. .
0.69
1326
 
Mephobarbital .
Mebaral .
Methylphenobarbitone .
N-Methylphenobarbital .
Prominal .
Methylphenobarbital .
A barbiturate that is metabolized to PHENOBARBITAL. It has been used for similar purposes, especially in EPILEPSY, but there is no evidence mephobarbital offers any advantage over PHENOBARBITAL. .
0.68
1133
 
Pentobarbital .
Diabutal .
Etaminal .
Ethaminal .
Nembutal .
Pentobarbital Sodium .
Pentobarbital, Monosodium Salt .
Pentobarbitone .
Sagatal .
Monosodium Salt Pentobarbital .
Mebubarbital .
Mebumal .
A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236) .
0.61
779050
 
Mebendazole .
Anti-Worm .
Bantenol .
Banworm .
Boots Threadworm Treatment .
Lomper .
Madicure .
Mebendan .
Mebenvet .
Pripsen Mebendazole .
R17635 .
Sqworm .
Sufil .
Surfont .
Telmin .
Vermicol .
Vermidil .
Vermin .
Vermox .
Wormkuur .
Anti Worm .
A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES. .
0.54
1171825
 
Walker-Warburg Syndrome .
COD-MD Syndrome .
Cerebroocular Dysplasia-Muscular Dystrophy Syndrome .
Congenital Muscular Dystrophy-Dystroglycanopathy with Brain and Eye Anomalies, Type A1 .
Fukuyama CMD .
Fukuyama Muscular Dystrophy .
Fukuyama Syndrome .
HARD Syndrome .
Hydrocephalus, Agyria, And Retinal Dysplasia .
LGMD2K .
MDDGA1 .
MEB (Muscle-Eye-Brain) Syndrome .
Muscle Eye Brain Disease .
Muscle-Eye-Brain Disease, POMT1-Related .
Muscular Dystrophy, Limb-Girdle, Autosomal Recessive, With Mental Retardation .
Muscular Dystrophy, Limb-Girdle, Type 2K .
Muscular Dystrophy-Dystroglycanopathy (Congenital with Brain and Eye Anomalies), Type A, 1 .
Muscular Dystrophy-Dystroglycanopathy (Limb-Girdle), Type C, 1 .
Pagon Syndrome .
CMD, Fukuyama .
COD MD Syndrome .
COD-MD Syndromes .
Cerebroocular Dysplasia Muscular Dystrophy Syndrome .
Congenital Muscular Dystrophy Dystroglycanopathy with Brain and Eye Anomalies, Type A1 .
Disease, POMT1-Related Muscle-Eye-Brain .
Diseases, POMT1-Related Muscle-Eye-Brain .
Dystrophy, Fukuyama Muscular .
HARD Syndromes .
Muscle Eye Brain Disease, POMT1 Related .
Muscle-Eye-Brain Diseases .
Muscle-Eye-Brain Diseases, POMT1-Related .
Muscular Dystrophy, Fukuyama .
POMT1-Related Muscle-Eye-Brain Disease .
POMT1-Related Muscle-Eye-Brain Diseases .
Pagon Syndromes .
Syndrome, COD-MD .
Syndrome, Chemke .
Syndrome, Fukuyama .
Syndrome, HARD .
Syndrome, Pagon .
Syndrome, Walker-Warburg .
Syndrome, Warburg .
Syndromes, COD-MD .
Syndromes, HARD .
Syndromes, Pagon .
Walker Warburg Syndrome .
alpha Dystroglycanopathies .
alpha-Dystroglycanopathies .
Cerebromuscular Dystrophy, Fukuyama Type .
Chemke Syndrome .
Fukuyama Congenital Muscular Dystrophy .
Fukuyama Type Congenital Muscular Dystrophy .
Muscle-Eye-Brain Disease .
Muscular Dystrophy, Congenital, Fukuyama Type .
Warburg Syndrome .
Rare autosomal recessive lissencephaly type 2 associated with congenital MUSCULAR DYSTROPHY and eye anomalies (e.g., RETINAL DETACHMENT; CATARACT; MICROPHTHALMOS). It is often associated with additional brain malformations such as HYDROCEPHALY and cerebellar hypoplasia and is the most severe form of the group of related syndromes (alpha-dystroglycanopathies) with common congenital abnormalities in the brain, eye and muscle development. .
0.34
293